This Toll Brothers Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Analysts initiated bullish coverage on Vita Coco, Toll Brothers, Civeo, Teva and Kura Oncology, with price targets of $70, $159, $42, $55 and $30.
Stocks · News reference
Civeo Affirms FY2026 Sales Guidance of $675.000M-$700.000M vs $686.186M Est
Civeo (NYSE:CVEO) affirms FY2026 sales outlook from $675.000 million-$700.000 million to $675.000 million-$700.000 million vs $686.186 million estimate.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Roth Capital Initiates Coverage On Civeo with Buy Rating, Announces Price Target of $39
Northland Capital Markets Initiates Coverage On Civeo with Outperform Rating, Announces Price Target of $42
Civeo shares are trading higher after Raymond James initiated coverage on the stock with a Strong Buy rating and announced a $51 price target.